Dr Reddy's Laboratories on Tuesday said it has launched Sorafenib tablets, used in the treatment of various cancers, in the US market after getting approval from the US Food and Drug Administration (USFDA)...
Important applications of Internet of Medical Things (IoMT) and how connected medical devices will deliver value and efficiency for health care providers.
With an aim to improve therapeutic regimens and ensure advancement in medical practice that is evidence based, the Indian Council of Medical Research (ICMR), the apex body in India for the formulation, coordination and promotion of biomedical...
U.S. Food and Drug Administration staff reviewers on Sunday said Pfizer-BioNTech's COVID-19 vaccines were effective and safe for use in children aged 6 months to 4 years...
French drugmaker Valneva said on Friday it had proposed a remediation plan after receiving the European Commission's notice of intent to terminate the advance purchase agreement for its inactivated COVID-19 vaccine candidate...
Global logistics service provider cargo-partner has announced its plan to expand to 10 more Indian cities in the next two-three years. After this expansion, cargo-partner will be present in over 24 cities and all major states of India.
Reddy's Laboratories on Thursday said its subsidiary has inked a pact with US-based Olema Pharmaceuticals Inc to research, develop and commercialise novel small molecule inhibitors of an undisclosed oncology target. Olema and Aurigene Discovery...
Serum Institute of India (SII) has applied to the country's drug regulator seeking market authorisation to manufacture indigenously developed India's first Quadrivalent Human Papillomavirus vaccine (qHPV) against cervical cancer, official sources...
Novavax, Inc. a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced the U.S. Food and Drug Administration (FDA) Vaccines and Related Biological Products...
German drugmaker Boehringer Ingelheim has obtained ad-interim injunctions against four domestic pharmaceutical companies that launched generic versions of Boehringer Ingelheim’s patent-protected drug Linagliptin, which is marketed under the brand...
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")